Connor, Clark & Lunn Investment Management (CC&L)’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.32M | Sell |
|
|||||
|
2024
Q4 | $2.81M | Sell |
|
|||||
|
2024
Q3 | $11.8M | Sell |
|
|||||
|
2024
Q2 | $8.85M | Buy |
|
|||||
|
2024
Q1 | $2.15M | Sell |
|
|||||
|
2023
Q4 | $1.78M | Sell |
|
|||||
|
2023
Q3 | $1.99M | Sell |
|
|||||
|
2023
Q2 | $3.04M | Buy |
|
|||||
|
2023
Q1 | $2.71M | Buy |
|
|||||
|
2022
Q4 | $3.16M | Buy |
|
|||||
|
2022
Q3 | $403K | Buy |
|
|||||
|
2022
Q2 | $62K | Buy |
|